modafinil has been researched along with Substance-Related Disorders in 41 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
Substance-Related Disorders: Disorders related to substance use or abuse.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The benefit (Epworth sleepiness score, ESS; visual analog scale, patient and clinician opinions) and risks (habituation, adverse effects) of modafinil were studied in a consecutive clinical cohort of 104 IH patients (59 with long sleep time) and 126 patients with narcolepsy/cataplexy." | 7.77 | Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. ( Arnulf, I; Dauvilliers, Y; Drouot, X; Franco, P; Golmard, JL; Lavault, S; Lecendreux, M; Leu-Semenescu, S, 2011) |
| "The benefit (Epworth sleepiness score, ESS; visual analog scale, patient and clinician opinions) and risks (habituation, adverse effects) of modafinil were studied in a consecutive clinical cohort of 104 IH patients (59 with long sleep time) and 126 patients with narcolepsy/cataplexy." | 3.77 | Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. ( Arnulf, I; Dauvilliers, Y; Drouot, X; Franco, P; Golmard, JL; Lavault, S; Lecendreux, M; Leu-Semenescu, S, 2011) |
| "Modafinil is a unique wake-promoting agent." | 2.69 | An evaluation of the abuse potential of modafinil using methylphenidate as a reference. ( Jasinski, DR, 2000) |
| "Modafinil (CRL 40476) is a vigilance-promoting, putative central alpha 1-adrenergic agonist with a pharmacological profile quite different from that of amphetamine." | 2.67 | Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil. ( Anderer, P; Frey, R; Grünberger, J; Mader, R; Saletu, B; Saletu, M, 1993) |
| "Modafinil- and placebo-treated patients improved continously over the 6-week period." | 2.67 | On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies. ( Frey, R; Grünberger, J; Mader, R; Saletu, B; Saletu, M; Zatschek, I, 1990) |
| " Side effects of stimulants are generally mild, short lived, and responsive to adjustments in dosage or timing." | 2.44 | Changes and challenges: managing ADHD in a fast-paced world. ( Bukstein, OG; Crismon, ML; Manos, MJ; Tom-Revzon, C, 2007) |
| "Respondents who had reported a psychiatric diagnosis declared higher subjective benefits of modafinil." | 1.56 | The off-prescription use of modafinil: An online survey of perceived risks and benefits. ( Rycroft, N; Smith-Spark, JH; Teodorini, RD, 2020) |
| "Modafinil is used because of its wakefulness-promoting properties for treatment of diseases associated with extreme sleepiness (i." | 1.48 | Modafinil in Forensic and Clinical Toxicology-Case Reports, Analytics and Literature. ( Andresen-Streichert, H; Radünz, L; Reuter, H, 2018) |
| "Modafinil was associated with DAAD in the total dataset (ROR, 2." | 1.46 | Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement. ( Connemann, BJ; Gahr, M; Schönfeldt-Lecuona, C; Zeiss, R, 2017) |
| "R-modafinil displays an in vitro profile different from cocaine." | 1.38 | R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. ( Cao, J; Katz, JL; Kopajtic, T; Loland, CJ; Mazier, S; Mereu, M; Newman, AH; Okunola, OM; Prisinzano, TE; Shi, L; Tanda, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (7.32) | 18.2507 |
| 2000's | 14 (34.15) | 29.6817 |
| 2010's | 21 (51.22) | 24.3611 |
| 2020's | 3 (7.32) | 2.80 |
| Authors | Studies |
|---|---|
| Reinert, JP | 1 |
| Dunn, RL | 1 |
| de Oliveira Cata Preta, B | 1 |
| Miranda, VIA | 1 |
| Bertoldi, AD | 1 |
| Teodorini, RD | 1 |
| Rycroft, N | 1 |
| Smith-Spark, JH | 1 |
| Tardelli, VS | 1 |
| Bisaga, A | 1 |
| Arcadepani, FB | 1 |
| Gerra, G | 1 |
| Levin, FR | 1 |
| Fidalgo, TM | 1 |
| Iglseder, B | 1 |
| Radünz, L | 1 |
| Reuter, H | 1 |
| Andresen-Streichert, H | 1 |
| Mereu, M | 2 |
| Bonci, A | 1 |
| Newman, AH | 2 |
| Tanda, G | 2 |
| McElhiney, M | 1 |
| Rabkin, J | 1 |
| Van Gorp, W | 1 |
| Rabkin, R | 2 |
| Dhillon, R | 1 |
| Wu, X | 1 |
| Bastiampillai, T | 1 |
| Tibrewal, P | 1 |
| Ram, SS | 1 |
| Hussainy, S | 1 |
| Henning, M | 1 |
| Jensen, M | 1 |
| Russell, B | 1 |
| Jerry, JM | 1 |
| Shirvani, N | 1 |
| Dale, R | 1 |
| Bisagno, V | 1 |
| González, B | 1 |
| Urbano, FJ | 1 |
| Dance, A | 1 |
| Gahr, M | 1 |
| Connemann, BJ | 1 |
| Schönfeldt-Lecuona, C | 1 |
| Zeiss, R | 1 |
| McElhiney, MC | 1 |
| Rabkin, JG | 1 |
| Nunes, EV | 1 |
| Volkow, ND | 1 |
| Fowler, JS | 1 |
| Logan, J | 1 |
| Alexoff, D | 1 |
| Zhu, W | 1 |
| Telang, F | 1 |
| Wang, GJ | 1 |
| Jayne, M | 1 |
| Hooker, JM | 1 |
| Wong, C | 1 |
| Hubbard, B | 1 |
| Carter, P | 1 |
| Warner, D | 1 |
| King, P | 1 |
| Shea, C | 1 |
| Xu, Y | 1 |
| Muench, L | 1 |
| Apelskog-Torres, K | 1 |
| Tahsili-Fahadan, P | 1 |
| Malcolm, R | 2 |
| Aston-Jones, G | 1 |
| Herin, DV | 1 |
| Rush, CR | 3 |
| Grabowski, J | 1 |
| Paterson, NE | 1 |
| Fedolak, A | 1 |
| Olivier, B | 1 |
| Hanania, T | 1 |
| Ghavami, A | 1 |
| Caldarone, B | 1 |
| Franke, AG | 1 |
| Lieb, K | 1 |
| Brady, KT | 1 |
| Gray, KM | 1 |
| Tolliver, BK | 1 |
| Lavault, S | 1 |
| Dauvilliers, Y | 1 |
| Drouot, X | 1 |
| Leu-Semenescu, S | 1 |
| Golmard, JL | 1 |
| Lecendreux, M | 1 |
| Franco, P | 1 |
| Arnulf, I | 1 |
| Wuo-Silva, R | 1 |
| Fukushiro, DF | 1 |
| Borçoi, AR | 1 |
| Fernandes, HA | 1 |
| Procópio-Souza, R | 1 |
| Hollais, AW | 1 |
| Santos, R | 1 |
| Ribeiro, LT | 1 |
| Corrêa, JM | 1 |
| Talhati, F | 1 |
| Saito, LP | 1 |
| Aramini, TC | 1 |
| Kameda, SR | 1 |
| Bittencourt, LR | 1 |
| Tufik, S | 1 |
| Frussa-Filho, R | 1 |
| Camenzind, M | 1 |
| Loland, CJ | 1 |
| Okunola, OM | 1 |
| Cao, J | 1 |
| Prisinzano, TE | 1 |
| Mazier, S | 1 |
| Kopajtic, T | 1 |
| Shi, L | 1 |
| Katz, JL | 1 |
| Estrada, A | 1 |
| Kelley, AM | 1 |
| Webb, CM | 1 |
| Athy, JR | 1 |
| Crowley, JS | 1 |
| Book, SW | 1 |
| Moak, D | 1 |
| DeVane, L | 1 |
| Czepowicz, V | 1 |
| Berigan, T | 1 |
| Stoops, WW | 1 |
| Lile, JA | 1 |
| Fillmore, MT | 1 |
| Glaser, PE | 1 |
| Kruszewski, SP | 2 |
| O'Brien, CP | 1 |
| Dackis, CA | 1 |
| Kampman, K | 1 |
| Ling, W | 2 |
| Rawson, R | 1 |
| Shoptaw, S | 1 |
| Kuehn, BM | 1 |
| Klotz, SG | 1 |
| Manos, MJ | 1 |
| Tom-Revzon, C | 1 |
| Bukstein, OG | 1 |
| Crismon, ML | 1 |
| Shearer, J | 1 |
| Saletu, B | 2 |
| Saletu, M | 2 |
| Grünberger, J | 2 |
| Frey, R | 2 |
| Anderer, P | 1 |
| Mader, R | 2 |
| Akerstedt, T | 1 |
| Ficca, G | 1 |
| Jasinski, DR | 1 |
| Kelly, TH | 1 |
| Hays, LR | 1 |
| Baker, RW | 1 |
| Wooten, AF | 1 |
| Zatschek, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls[NCT02051153] | 64 participants (Actual) | Interventional | 2009-10-31 | Completed | |||
| A Randomized, Double Blind, Placebo Controlled Evaluation of Modafinil vs Placebo for the Treatment of General Anesthesia Related Delayed Emergence in Patients With the Diagnosis of Obstructive Sleep Apnea[NCT02494102] | Phase 4 | 105 participants (Actual) | Interventional | 2016-02-29 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Length of time of above compared between groups (NCT02494102)
Timeframe: 24 hours
| Intervention | minutes (Mean) |
|---|---|
| Placebo | 53.5 |
| Modafinil | 61.0 |
Postanesthesia quality recovery scale (PQRS). Component and aggregate scoring on the scale. Measures physiology, nociceptive, emotional activities of daily living cognitive and overall patient perspective. The scale is dimensionless and the aggregate of all individually tested dimensions is scaled from 17-65. A higher value implies improved postanesthesia recovery. Mean difference was assessed in each patient and aggregated thus patients with no difference between pre- and post-operative scores were zeroed (received a zero score if the difference was zero). A negative value was associated with worse outcome. (NCT02494102)
Timeframe: baseline and 6 hours after surgery
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | -5.67 |
| Modafinil | -8.91 |
12 reviews available for modafinil and Substance-Related Disorders
| Article | Year |
|---|---|
Management of overdoses of loperamide, gabapentin, and modafinil: a literature review.
Topics: Drug Overdose; Emergency Treatment; Gabapentin; Humans; Loperamide; Modafinil; Substance-Related Dis | 2019 |
Management of overdoses of loperamide, gabapentin, and modafinil: a literature review.
Topics: Drug Overdose; Emergency Treatment; Gabapentin; Humans; Loperamide; Modafinil; Substance-Related Dis | 2019 |
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Topics: Amphetamine; Central Nervous System Stimulants; Cocaine; Double-Blind Method; Humans; Lisdexamfetami | 2020 |
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Topics: Amphetamine; Central Nervous System Stimulants; Cocaine; Double-Blind Method; Humans; Lisdexamfetami | 2020 |
[Doping for the brain].
Topics: Aged; Amphetamines; Brain; Cognitive Aging; Dietary Supplements; Humans; Illicit Drugs; Methylphenid | 2018 |
[Doping for the brain].
Topics: Aged; Amphetamines; Brain; Cognitive Aging; Dietary Supplements; Humans; Illicit Drugs; Methylphenid | 2018 |
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.
Topics: Benzhydryl Compounds; Brain; Cognition; Dopamine; Dopamine Plasma Membrane Transport Proteins; Human | 2013 |
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.
Topics: Benzhydryl Compounds; Brain; Cognition; Dopamine; Dopamine Plasma Membrane Transport Proteins; Human | 2013 |
Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine; Dopamine; Humans; Methamp | 2016 |
Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine; Dopamine; Humans; Methamp | 2016 |
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
Topics: Animals; Behavior Therapy; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clini | 2010 |
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
Topics: Animals; Behavior Therapy; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clini | 2010 |
[Pharmacological neuroenhancement and brain doping : Chances and risks].
Topics: Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Cross-Sectional Studies; Dose-Respon | 2010 |
[Pharmacological neuroenhancement and brain doping : Chances and risks].
Topics: Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Cross-Sectional Studies; Dose-Respon | 2010 |
Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
Topics: Adrenergic Agents; Benzhydryl Compounds; Central Nervous System Stimulants; Cholinesterase Inhibitor | 2011 |
Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
Topics: Adrenergic Agents; Benzhydryl Compounds; Central Nervous System Stimulants; Cholinesterase Inhibitor | 2011 |
Management of methamphetamine abuse and dependence.
Topics: Baclofen; Benzhydryl Compounds; Brain; Bupropion; Cognition Disorders; Cognitive Behavioral Therapy; | 2006 |
Management of methamphetamine abuse and dependence.
Topics: Baclofen; Benzhydryl Compounds; Brain; Bupropion; Cognition Disorders; Cognitive Behavioral Therapy; | 2006 |
Changes and challenges: managing ADHD in a fast-paced world.
Topics: Algorithms; Antihypertensive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hype | 2007 |
Changes and challenges: managing ADHD in a fast-paced world.
Topics: Algorithms; Antihypertensive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hype | 2007 |
The principles of agonist pharmacotherapy for psychostimulant dependence.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Dopamine Agonists; Heroin Dependence; Human | 2008 |
The principles of agonist pharmacotherapy for psychostimulant dependence.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Dopamine Agonists; Heroin Dependence; Human | 2008 |
Alertness-enhancing drugs as a countermeasure to fatigue in irregular work hours.
Topics: Amphetamine; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Fatigue; Humans; Mod | 1997 |
Alertness-enhancing drugs as a countermeasure to fatigue in irregular work hours.
Topics: Amphetamine; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Fatigue; Humans; Mod | 1997 |
6 trials available for modafinil and Substance-Related Disorders
| Article | Year |
|---|---|
Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Benzhydryl Compounds; CD4 Lymphocyte Count; Central | 2013 |
Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Benzhydryl Compounds; CD4 Lymphocyte Count; Central | 2013 |
Modafinil as a replacement for dextroamphetamine for sustaining alertness in military helicopter pilots.
Topics: Adult; Aerospace Medicine; Aircraft; Arousal; Benzhydryl Compounds; Central Nervous System Stimulant | 2012 |
Modafinil as a replacement for dextroamphetamine for sustaining alertness in military helicopter pilots.
Topics: Adult; Aerospace Medicine; Aircraft; Arousal; Benzhydryl Compounds; Central Nervous System Stimulant | 2012 |
Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil.
Topics: Adult; Alcoholism; Analysis of Variance; Benzhydryl Compounds; Brain; Brain Mapping; Central Nervous | 1993 |
Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil.
Topics: Adult; Alcoholism; Analysis of Variance; Benzhydryl Compounds; Brain; Brain Mapping; Central Nervous | 1993 |
An evaluation of the abuse potential of modafinil using methylphenidate as a reference.
Topics: Adult; Appetite; Arousal; Benzhydryl Compounds; Central Nervous System Stimulants; Cross-Over Studie | 2000 |
An evaluation of the abuse potential of modafinil using methylphenidate as a reference.
Topics: Adult; Appetite; Arousal; Benzhydryl Compounds; Central Nervous System Stimulants; Cross-Over Studie | 2000 |
Acute behavioral and physiological effects of modafinil in drug abusers.
Topics: Adult; Behavior; Benzhydryl Compounds; Blood Pressure; Central Nervous System Stimulants; Cocaine-Re | 2002 |
Acute behavioral and physiological effects of modafinil in drug abusers.
Topics: Adult; Behavior; Benzhydryl Compounds; Blood Pressure; Central Nervous System Stimulants; Cocaine-Re | 2002 |
On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies.
Topics: Adrenergic alpha-Agonists; Adult; Alcoholism; Attention; Benzhydryl Compounds; Blood Pressure; Centr | 1990 |
On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies.
Topics: Adrenergic alpha-Agonists; Adult; Alcoholism; Attention; Benzhydryl Compounds; Blood Pressure; Centr | 1990 |
23 other studies available for modafinil and Substance-Related Disorders
| Article | Year |
|---|---|
Psychostimulant Use for Neuroenhancement (Smart Drugs) among College Students in Brazil.
Topics: Brazil; Central Nervous System Stimulants; Cognition; Cross-Sectional Studies; Humans; Methylphenida | 2020 |
Psychostimulant Use for Neuroenhancement (Smart Drugs) among College Students in Brazil.
Topics: Brazil; Central Nervous System Stimulants; Cognition; Cross-Sectional Studies; Humans; Methylphenida | 2020 |
The off-prescription use of modafinil: An online survey of perceived risks and benefits.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Internet; Male; Mental Di | 2020 |
The off-prescription use of modafinil: An online survey of perceived risks and benefits.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Internet; Male; Mental Di | 2020 |
Modafinil in Forensic and Clinical Toxicology-Case Reports, Analytics and Literature.
Topics: Accidents, Traffic; Adult; Analytic Sample Preparation Methods; Benzhydryl Compounds; Cadaver; Calib | 2018 |
Modafinil in Forensic and Clinical Toxicology-Case Reports, Analytics and Literature.
Topics: Accidents, Traffic; Adult; Analytic Sample Preparation Methods; Benzhydryl Compounds; Cadaver; Calib | 2018 |
Could modafinil be a drug of dependence?
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Disorders of Excessive Somnolence; Humans; Male | 2015 |
Could modafinil be a drug of dependence?
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Disorders of Excessive Somnolence; Humans; Male | 2015 |
Prevalence of cognitive enhancer use among New Zealand tertiary students.
Topics: Adult; Amphetamines; Benzhydryl Compounds; Female; Humans; Male; Methylphenidate; Modafinil; Motivat | 2016 |
Prevalence of cognitive enhancer use among New Zealand tertiary students.
Topics: Adult; Amphetamines; Benzhydryl Compounds; Female; Humans; Male; Methylphenidate; Modafinil; Motivat | 2016 |
Addiction to Armodafinil and Modafinil Presenting With Paranoia.
Topics: Benzhydryl Compounds; Humans; Male; Middle Aged; Modafinil; Paranoid Disorders; Substance-Related Di | 2016 |
Addiction to Armodafinil and Modafinil Presenting With Paranoia.
Topics: Benzhydryl Compounds; Humans; Male; Middle Aged; Modafinil; Paranoid Disorders; Substance-Related Di | 2016 |
Smart drugs: A dose of intelligence.
Topics: Aging; Amphetamines; Animals; Benzhydryl Compounds; Biomedical Enhancement; Caffeine; Child; Cogniti | 2016 |
Smart drugs: A dose of intelligence.
Topics: Aging; Amphetamines; Animals; Benzhydryl Compounds; Biomedical Enhancement; Caffeine; Child; Cogniti | 2016 |
Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement.
Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Au | 2017 |
Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement.
Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Au | 2017 |
Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot study.
Topics: Adult; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; HIV Infections; Homosexual | 2009 |
Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot study.
Topics: Adult; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; HIV Infections; Homosexual | 2009 |
Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.
Topics: Adult; Benzhydryl Compounds; Brain; Carbon Radioisotopes; Caudate Nucleus; Central Nervous System St | 2009 |
Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.
Topics: Adult; Benzhydryl Compounds; Brain; Carbon Radioisotopes; Caudate Nucleus; Central Nervous System St | 2009 |
Modafinil: an anti-relapse medication.
Topics: Animals; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Humans; Modafinil; Radionuc | 2010 |
Modafinil: an anti-relapse medication.
Topics: Animals; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Humans; Modafinil; Radionuc | 2010 |
Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.
Topics: Animals; Benzhydryl Compounds; Biogenic Monoamines; Central Nervous System Stimulants; Cocaine; Dopa | 2010 |
Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.
Topics: Animals; Benzhydryl Compounds; Biogenic Monoamines; Central Nervous System Stimulants; Cocaine; Dopa | 2010 |
Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.
Topics: Adult; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Cohort Studies; Databases | 2011 |
Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.
Topics: Adult; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Cohort Studies; Databases | 2011 |
Addictive potential of modafinil and cross-sensitization with cocaine: a pre-clinical study.
Topics: Animals; Benzhydryl Compounds; Brain; Central Nervous System Sensitization; Central Nervous System S | 2011 |
Addictive potential of modafinil and cross-sensitization with cocaine: a pre-clinical study.
Topics: Animals; Benzhydryl Compounds; Brain; Central Nervous System Sensitization; Central Nervous System S | 2011 |
[Brain doping. With smart pills becoming the perfect human being].
Topics: Achievement; Adolescent; Adult; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Chil | 2012 |
[Brain doping. With smart pills becoming the perfect human being].
Topics: Achievement; Adolescent; Adult; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Chil | 2012 |
R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Plasma | 2012 |
R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Plasma | 2012 |
Clinical applications of modafinil in stimulant abusers: low abuse potential.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Female; Humans; Male; Modafinil; Neu | 2002 |
Clinical applications of modafinil in stimulant abusers: low abuse potential.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Female; Humans; Male; Modafinil; Neu | 2002 |
Modafinil treatment of excessive sedation associated with divalproex sodium.
Topics: Adult; Antimanic Agents; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System Stimulants; | 2004 |
Modafinil treatment of excessive sedation associated with divalproex sodium.
Topics: Adult; Antimanic Agents; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System Stimulants; | 2004 |
Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration.
Topics: Adult; Arousal; Benzhydryl Compounds; Central Nervous System Stimulants; Dose-Response Relationship, | 2005 |
Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration.
Topics: Adult; Arousal; Benzhydryl Compounds; Central Nervous System Stimulants; Dose-Response Relationship, | 2005 |
Euphorigenic and abusive properties of modafinil.
Topics: Affective Symptoms; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine-Related Disorde | 2006 |
Euphorigenic and abusive properties of modafinil.
Topics: Affective Symptoms; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine-Related Disorde | 2006 |
Does modafinil produce euphoria?
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine-Related Disorders; Euphoria; Humans | 2006 |
Does modafinil produce euphoria?
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine-Related Disorders; Euphoria; Humans | 2006 |
Brain scans, genes provide addiction clues.
Topics: Benzhydryl Compounds; Brain; Brain Chemistry; Central Nervous System Agents; Humans; Modafinil; Mono | 2007 |
Brain scans, genes provide addiction clues.
Topics: Benzhydryl Compounds; Brain; Brain Chemistry; Central Nervous System Agents; Humans; Modafinil; Mono | 2007 |
Modafinil: mischaracterization.
Topics: Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulan | 2007 |
Modafinil: mischaracterization.
Topics: Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulan | 2007 |